"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the acquisition of Cavion, Inc. through a merger with a Jazz subsidiary for a total potential consideration of $312.5 million.

Cavion, a clinical-stage biotechnology company and now a wholly-owned subsidiary of Jazz, creates therapies aimed at modulating the T-type calcium channel for the treatment of chronic and rare neurological diseases.

read more

Apply by August 15th!!!

Introduce your company to targeted investors, VCs, and potential partners at the 2019 Southeast BIO Investor & Partnering Forum by presenting.

read more

AskBio acquires Scottish biotech

Emboldened by a recent cash infusion of $225 million from investors, AskBio, a clinical stage gene therapy company in Research Triangle Park, has acquired a Scottish company to help it develop therapeutics for a wider array of genetic disorders than the rare diseases it has targeted to date.

read more